Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
TRMED | Oslo | NOK | Real-time | |
TRMEDo | BATS Europe | NOK | Delayed | |
0R6Y | London | NOK | Real-time | |
TRMEDNOK | Stockholm | NOK | Real-time |
Period Ending: | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
---|---|---|---|---|
Total Revenue | 0 | |||
Gross Profit | ||||
Operating Income | -57.12 | -57.12 | -102.84 | -100.28 |
Net Income | -57.35 | -57.35 | -91.69 | -104.85 |
Period Ending: | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
---|---|---|---|---|
Total Assets | 109.64 | 109.64 | 311.57 | 379.4 |
Total Liabilities | 45.8 | 45.8 | 129.02 | 108.12 |
Total Equity | 63.84 | 63.84 | 182.55 | 271.28 |
Period Ending: | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | -91.32 | -91.32 | -78.41 | -148.03 |
Cash From Investing Activities | -1.3 | -1.3 | 0.095 | 0.036 |
Cash From Financing Activities | -0.612 | -0.612 | -1.56 | 230.9 |
Net Change in Cash | -94.36 | -94.36 | -68.87 | 78.61 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review